- Home
- IMAB vs IH Comparison
IMAB vs IH Comparison
Compare IMAB & IH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMAB
- IH
- Stock Information
- Founded
- IMAB 2014
- IH 1996
- Country
- IMAB United States
- IH China
- Employees
- IMAB N/A
- IH N/A
- Industry
- IMAB Biotechnology: Pharmaceutical Preparations
- IH Other Consumer Services
- Sector
- IMAB Health Care
- IH Real Estate
- Exchange
- IMAB Nasdaq
- IH Nasdaq
- Market Cap
- IMAB 79.9M
- IH 118.5M
- IPO Year
- IMAB 2020
- IH 2020
- Fundamental
- Price
- IMAB $0.84
- IH $2.59
- Analyst Decision
- IMAB Strong Buy
- IH
- Analyst Count
- IMAB 3
- IH 0
- Target Price
- IMAB $8.00
- IH N/A
- AVG Volume (30 Days)
- IMAB 216.1K
- IH 156.0K
- Earning Date
- IMAB 03-21-2025
- IH 03-25-2025
- Dividend Yield
- IMAB N/A
- IH 3.24%
- EPS Growth
- IMAB N/A
- IH N/A
- EPS
- IMAB N/A
- IH 0.28
- Revenue
- IMAB $569,464.00
- IH $134,002,994.00
- Revenue This Year
- IMAB N/A
- IH $15.90
- Revenue Next Year
- IMAB N/A
- IH $8.64
- P/E Ratio
- IMAB N/A
- IH $7.95
- Revenue Growth
- IMAB N/A
- IH N/A
- 52 Week Low
- IMAB $0.76
- IH $1.47
- 52 Week High
- IMAB $2.00
- IH $2.60
- Technical
- Relative Strength Index (RSI)
- IMAB 38.53
- IH 75.24
- Support Level
- IMAB $0.78
- IH $2.21
- Resistance Level
- IMAB $0.93
- IH $2.40
- Average True Range (ATR)
- IMAB 0.07
- IH 0.16
- MACD
- IMAB -0.01
- IH 0.04
- Stochastic Oscillator
- IMAB 33.45
- IH 98.74
About IMAB I-MAB
I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).
About IH iHuman Inc.
iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources. The majority of iHuman Inc's revenue comes from mainland China.